References
1. Lee W.M., Larson A.M., Stravitz R.T. (2011) AASLD position paper: the management of acute liver failure: update 2011.
2. Bernal W., Hyyrylainen A., Gera A. et al. (2013) Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J. Hepatol., 59(1): 74–80.
3. Trey C., Davidson C.S. (1970) The management of fulminant hepatic failure. Prog. Liver Dis., 3: 282–298.
4. Polson J., Lee W.M. (2005) American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatol., 41(5): 1179–1197.
5. Arroyo V., Moreau R., Jalan R. (2020) Acute-on-Chronic Liver Failure. N. Engl. J. Med., 382(22): 2137–2145. doi: 10.1056/NEJMra1914900.
6. Jalan R., Williams R. (2002) Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif., 20: 252–261.
7. Ichai P., Samuel D. (2008) Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl., 14(Suppl 2): 67–79.
8. Pievsky D., Rustgi N., Nikolaos T.P. (2018) Classification and Epidemiologic Aspects of Acute Liver Failure. Clinics in Liver Disease, 22(2): 229–241. doi:10.1016/j.cld.2018.01.001.
9. Westbrook R.H., Yeoman A.D., Joshi D. et al. (2010) Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am. J. Transplant., 10: 2520–2526.
10. Chung R.T., Stravitz R.T., Fontana R.J. et al. (2012) Pathogenesis of liver injury in acute liver failure. Gastroenterol., 43(3): e1–e7. doi: 10.1053/j.gastro.2012.07.011.
11. Думанский Ю.В., Кабанова Н.В., Верхулецкий И.Е. и др. (2012) Острая печеночная недостаточность. Мед. неотл. сост., 6(45): 85–95.
12. Бондар М.В. (2012) Сучасні аспекти інтенсивної терапії печінкової енцефалопатії з позиції доказової медицини. Медицина невідкладних станів, 6(45): www.mif-ua.com/archive/article/34354.
13. Davern T.J. (2007) Predicting prognosis in acute liver failure: Ammonia and the risk of cerebral edema. Hepatol., 46(6): 1679–1681.
14. Bhatia V., Rajbir S., Acharya S.K. (2006) Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut, 55(1): 98–104.
15. Shakil A.O., Kramer D., Mazariegosal G.V. (2000) Acute liver failure: Clinical features, outcomeanalysis, and applicability of prognostic criteria. Liver Transplant., 6(2): 163–169.
16. European Association for the Study of the Liver (2017) EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J. Hepatol., 66: 1047–1081.
17. Лукашик С.П., Карпов І.А., Яговдик-Тележна Е.Н., Юркевич І.В. (2013) Гостра печінкова недостатність і методи її корекції. Гепатологія, 3: 21–39.
18. Rose C., Michalak A., Rao K.V.R. et al. (1999) L-Ornithine-L-Aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatol., 30: 636–640.
19. Kovalic A.J., Lee T.P., Da B.L. (2022) L‐ornithine L‐aspartate in acute treatment of severe hepatic encephalopathy: a double‐blind randomized controlled trial. Hepatol., 76(5): E108–E109. doi: 10.1002/hep.32643.
20. Jain A., Sharma B.C., Mahajan B. et al. (2022) L-Ornithine-L-aspartate in acute treatment of severe hepatic encephalopathy: a double‐blind randomized controlled trial. Hepatol., 75(5): 1194–1203. doi: 10.1002/hep.32255.